PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 150 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,415,000 | -10.2% | 275,200 | -9.8% | 0.02% | -13.6% |
| Q3 2019 | $1,575,000 | -14.7% | 305,200 | 0.0% | 0.02% | -8.3% |
| Q2 2019 | $1,846,000 | -16.4% | 305,200 | 0.0% | 0.02% | -11.1% |
| Q1 2019 | $2,207,000 | -2.3% | 305,200 | 0.0% | 0.03% | -10.0% |
| Q4 2018 | $2,258,000 | +12.7% | 305,200 | -17.6% | 0.03% | +57.9% |
| Q3 2018 | $2,003,000 | +52.4% | 370,200 | 0.0% | 0.02% | +46.2% |
| Q2 2018 | $1,314,000 | +266.0% | 370,200 | +111.5% | 0.01% | +225.0% |
| Q1 2018 | $359,000 | -81.6% | 175,000 | -29.7% | 0.00% | -90.9% |
| Q4 2014 | $1,953,000 | +59.7% | 249,100 | 0.0% | 0.04% | +41.9% |
| Q3 2014 | $1,223,000 | -20.5% | 249,100 | 0.0% | 0.03% | -22.5% |
| Q2 2014 | $1,539,000 | +15.0% | 249,100 | -0.4% | 0.04% | +5.3% |
| Q1 2014 | $1,338,000 | +2.7% | 250,150 | +0.4% | 0.04% | -5.0% |
| Q4 2013 | $1,303,000 | -14.9% | 249,100 | -10.2% | 0.04% | -23.1% |
| Q3 2013 | $1,532,000 | +8.7% | 277,500 | -50.2% | 0.05% | -7.1% |
| Q2 2013 | $1,410,000 | – | 557,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB Management Ltd | 8,156,107 | $208,389,000 | 21.35% |
| Casdin Capital, LLC | 7,990,652 | $204,161,000 | 5.08% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,444,959 | $36,919,000 | 4.60% |
| BOURNE LENT ASSET MANAGEMENT INC | 552,850 | $14,125,000 | 4.05% |
| Jackson Square Partners, LLC | 14,536,671 | $371,411,000 | 2.36% |
| Abacus Planning Group, Inc. | 180,000 | $4,599,000 | 1.46% |
| ARK Investment Management | 22,723,075 | $580,575,000 | 1.39% |
| Nikko Asset Management Americas, Inc. | 9,348,002 | $236,037,000 | 1.01% |
| AtonRa Partners | 94,300 | $2,409,000 | 0.80% |
| SANDLER CAPITAL MANAGEMENT | 300,000 | $7,665,000 | 0.68% |